SECURITIES OBSERVER INC reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market

Pressure BioSciences CEO sees increased revenue on projects and services in 2018




Pressure BioSciences (OTCMKTS:PBIOChief Richard Schumacher discloses to Proactive Investors the existence science aggregate revealed a bounce in first-quarter income on account of an uptick in instrument deals, and said the organization has contracted its obligation. 


Schumacher says the organization is exceptionally glad for their advance, having done $2.2mln in deals in 2017. He says the organization has procured more deals staff and touted another weight chamber instrument that takes into account various "extravagant accessories" for scientists